The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease

Journal of Experimental Medicine

Volumn 195, Issue 9, 2002, Pages 1129-1143

  Neurath, M F ^a,b,e   Weigmann, B ^a   Finotto, S ^a   Glickman, J ^d   Nieuwenhuis, E ^b   Iijima, H ^b   Mizoguchi, A ^d   Mizoguchi, E ^d   Mudter, J ^a   Galle, P R ^a   Bhan, A ^d   Autschbach, F ^e   Sullivan, B M ^c   Szabo, S J ^c   Glimcher, L H ^c   Blumberg, R S ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Colitis; Cytokines; GATA 3; IFN ; T bet

Indexed keywords

CD4 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENTERITIS; FEMALE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MUCOSA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RETROVIRUS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ADULT; ANIMALS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; CROHN DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENES, RAG-1; HOMEODOMAIN PROTEINS; HUMANS; IMMUNITY, MUCOSAL; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; MIDDLE AGED; POLYMERASE CHAIN REACTION; SPLEEN; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; TRANSCRIPTION FACTORS;

EID: 0037029649     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011956     Document Type: Article

References (68)

1. Inflammatory bowel disease
2. Immunology of inflammatory bowel disease
3. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease
4. Inflammatory bowel disease
5. Crohn's disease
6. Experimental models of inflammatory bowel disease
7. Postoperative recurrence of Crohn's disease: The enemy is within the fecal stream
8. Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
9. Interleukin-2 and interferon-γ secreting T cells in normal and diseased human intestinal mucosa
10. + lamina propria (LP) lymphocyte secretion profiles in inflammatory bowel disease
11. Blockade of IL-6 trans-signaling suppresses T cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn's disease and experimental colitis in vivo
12. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice
13. A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease
14. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease
15. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production
16. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway
17. + T cells
18. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance
19. Treatment of experimental (TNBS)-colitis by intranasal administration of TGF-β1 plasmid: TGF-β1-mediated suppression of Th1 response occurs by IL-10 induction and IL-12Rb2 chain down-regulation
20. STATs and cytokine specificity
21. Transcriptional regulation of Th1/Th2 polarization
22. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets
23. Transcription factors of the NFAT family: Regulation and function
24. Stability and commitment in T helper cell development
25. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation
26. The transcription factor c-maf controls the production of interleukin-4 but not other Th2 cytokines
27. + T cells
28. Lineage commitment in the immune system: The T helper lymphocyte grows up
29. Ectopic expression of activated STAT-6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells
30. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc
31. Stat-6 independent GATA-3 autoactivation directs IL-4 independent Th2 development and commitment
32. Inhibition of Th1 development mediated by GATA-3 through an IL-4 independent mechanism
33. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level
34. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons
35. Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet?
36. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biologic activities similar as well as distinct from IL-12
37. + T cells
38. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
39. A novel transcription factor, T-bet, directs Th1 lineage commitment
40. Treatment of allergic airway inflammation and hyperresponsiveness by local antisense-induced blockade of GATA-3 expression
41. T-bet is essential for Th1 lineage commitment and IFN-γ production in CD4 but not CD8 T cells
42. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet
43. The critical role for interleukin-4 but not interferon-γ in the pathogenesis of colitis in T-cell receptor α mutant mice
44. Interleukin-10 deficient mice develop chronic enterocolitis
45. Antibodies to IL-12 abrogate established experimental colitis in mice
46. Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette
47. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin-4
48. + T cells
49. + T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45KB surface phenotype
50. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation
51. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production
52. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β
53. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
54. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells
55. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection
56. Repression of IL-4 induced gene expression by IFN-γ requires STAT-1 activation
57. Interferons inhibit activation of STAT-6 by interleukin-4 in human monocytes by inducing SOCS-1 gene expression
58. SOCS proteins, regulators of intracellular signaling
59. Interleukin-12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells
60. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease
61. Transforming growth factor β induces nuclear import of Smad3 in an importin-β1 and Ran-dependent manner
62. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
63. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling
64. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling
65. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-β receptor for degradation
66. Targeted disruption of the mouse transforming growth factor β-1 gene results in multifocal inflammatory disease
67. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death
68. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated